Results from the iDose TR exchange trial showed a second administration and removal of the original implant was safe and well tolerated over 12 months.
Dealbreaker on MSN
Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...
According to Leadoptik's FDA application, the LIA catheter is an OCT-guided biopsy needle designed for use with endobronchial ...
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
Phraxis Inc. today announced the successful initiation of its Post-Approval Study (PAS) for the EndoForce™ Anastomotic ...
April 9, 2010 — In its latest effort to reduce the risks of medical radiation, the US Food and Drug Administration (FDA) yesterday notified manufacturers of radiotherapy equipment such as linear ...
As most new moms know, post-baby weight can be frustratingly hard to lose. That's why Jennifer, a 24 year old mom from Dallas-Fort Worth, Texas chose to get a little help with an ORBERA™ Intragastric ...
In the first year of the second Trump administration, we have seen the Food and Drug Administration (FDA) take an ...
Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include novel drugs that offer new treatment options, as well as first generics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results